Get started
Award

21XD1403400

Funded outputs count: 10
Funder award ID: 21XD1403400
OpenAlex ID: G2046354537
Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
2024 · Yuan-ye Zeng, Qing Gu, et al. · Acta Pharmacologica Sinica · 23
PDF
Application of biodegradable microsphere injections: an anticancer perspective
2024 · Huanhuan Cai, Aixue Li, et al. · Materials Advances · 15
PDF
Stimuli-responsive polymer microneedles: A rising transdermal drug delivery system and Its applications in biomedical
2023 · Rongmei Liu, Aixue Li, et al. · Journal of Drug Delivery Science and Technology · 46
Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy
2023 · Yunan Zhao, Yongwei Gu, et al. · Materials & Design · 16
Plant-derived nanovesicles: Further exploration of biomedical function and application potential
2023 · Aixue Li, Dan Li, et al. · Acta Pharmaceutica Sinica B · 146
αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma
2022 · Yongwei Gu, Yue Du, et al. · Journal of Nanobiotechnology · 70
PDF
The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
2022 · Pan Zhang, Chao Qin, et al. · Biomaterials · 66
Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer
2022 · Xiaomeng Tang, Dan Li, et al. · Theranostics · 17
PDF
Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis
2021 · Xiaomeng Tang, Meng Yang, et al. · Drug Design Development and Therapy · 16
PDF
Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy
2021 · Liangdi Jiang, Yongwei Gu, et al. · ACS Applied Materials & Interfaces · 83